Latest news for McRae Industries (OTC:MCRAB) Stock

McRae Industries

McRae Industries Inc operates in the footwear industry. Its principal lines of business are manufacturing and selling military combat boots and importing and selling western and work boots. It operates through the Western and Lifestyle Segments. The Western and Lifestyle segment, which is the key revenue driver, includes western, ladies fashion, and children's footwear products under the Dan Post, Dingo, and Laredo Western Boots brand names.

MCRAE INDUS INC B by McRae Industries, Inc.

McRae Industries Inc

Emeren Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) lowers FY2024 sales outlook from $150.00 million-160.00 million to $97.00 million-102.00 million.

News

Guidance

Emeren Group Lowers FY2024 Sales Guidance from $150.00M-$160.00M to $97.00M-$102.00M  VS Est. $151.34M

Precision Optics Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POCI#NASDAQ">POCI</a>) reported quarterly losses of $(0.21) per share. This is a 162.5 percent decrease over losses of $(0.08) per share from the same period last year. The company reported $4.20 million in sales this quarter. This is a 2.88 percent decrease over sales of $4.32 million the same period last year.

Earnings

POCI

Precision Optics Corp Q1 EPS $(0.21) Down From $(0.08) YoY, Sales $4.20M Down From $4.32M YoY

Contracts

AXON

Axon To Supply Royal Canadian Mounted Police (RCMP) With Body-Worn Cameras

Ryvyl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVYL#NASDAQ">RVYL</a>) reported quarterly losses of $(0.76) per share which missed the analyst consensus estimate of $(0.27) by 181.48 percent. This is a 26.67 percent decrease over losses of $(0.60) per share from the same period last year. The company reported quarterly sales of $12.61 million which missed the analyst consensus estimate of $13.92 million by 9.44 percent. This is a 27.88 percent decrease over sales of $17.48 million the same period last year.

Earnings Misses

RVYL

Ryvyl Q3 EPS $(0.76) Misses $(0.27) Estimate, Sales $12.61M Miss $13.92M Estimate

Hyliion Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HYLN#NYSE">HYLN</a>) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 14.29 percent.

Earnings Beats

HYLN

Hyliion Holdings Q3 2024 GAAP EPS $(0.06) Beats $(0.07) Estimate

Super League Enterprise (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLE#NASDAQ">SLE</a>) reported quarterly losses of $(0.25) per share which beat the analyst consensus estimate of $(0.31) by 19.35 percent. This is a 78.45 percent increase over losses of $(1.16) per share from the same period last year. The company reported quarterly sales of $4.43 million which missed the analyst consensus estimate of $6.81 million by 34.91 percent. This is a 38.42 percent decrease over sales of $7.20 million the same period last year.

Super League Enterprise Q3 2024 Adj EPS $(0.25) Beats $(0.31) Estimate, Sales $4.43M Miss $6.81M Estimate

Biotech

Events

General

AMGN

Amgen To Present MITIGATE Phase 3 Study At ACR 2024 Nov. 14-19

Trading Ideas

WYNN

Appaloosa LP 13F Shows Added Stake In Vistra Corp With 1,270,388 Shares; Added Stake In NRG Energy With 999,820 Shares; Added Stake In Las Vegas Sands Corp With 1,528,323 Shares; Added Stake In Wynn Resorts Ltd With 800,000 Shares

Sidus Space (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIDU#NASDAQ">SIDU</a>) reported quarterly losses of $(0.93) per share. This is a 81.4 percent increase over losses of $(5.00) per share from the same period last year. The company reported $1.87 million in sales this quarter. This is a 89.65 percent increase over sales of $985.52 thousand the same period last year.

SIDU

Sidus Space Q3 EPS $(0.93) Up From $(5.00) YoY, Sales $1.87M Up From $985.52K YoY

Emeren Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOL#NYSE">SOL</a>) sees Q4 sales of $40.000 million-45.000 million vs $80.26 million estimate.

Emeren Group Sees Q4 Sales $40.000M-45.000M vs $80.26M Est

Tivic Health Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) reported quarterly losses of $(0.23) per share. This is a 84.46 percent increase over losses of $(1.48) per share from the same period last year. The company reported $126.00 thousand in sales this quarter. This is a 55.32 percent decrease over sales of $282.00 thousand the same period last year.

TIVC

Tivic Health Systems Q3 EPS $(0.23) Up From $(1.48) YoY, Sales $126.00K Down From $282.00K YoY

WIIM

DMRC

Digimarc shares are trading lower after the company reported worse-than-expected Q3 financial results.

Genelux (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLX#NASDAQ">GNLX</a>) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.20) by 5 percent.

GNLX

Genelux Q3 2024 GAAP EPS $(0.19) Beats $(0.20) Estimate

2024 Fourth Quarter and Full Year Outlook
Based on current market conditions, Globant is providing the following estimates for the fourth quarter and the full year of 2024:
<ul>
<li>Fourth quarter 2024 Revenues are estimated to be in the range of $642.0 million to $648.0 million, or 10.6% to 11.6% year-over-year growth.</li>
<li>Fourth quarter 2024 Non-IFRS Adjusted Profit from Operations Margin is estimated to be in the range of 15.0% to 16.0%.</li>
<li>Fourth quarter 2024 Non-IFRS Adjusted Diluted EPS is estimated to be in the range of $1.71 to $1.75 (assuming an average of 44.7 million diluted shares outstanding during the fourth quarter).</li>
<li>Fiscal year 2024 Revenues are estimated to be in the range of $2,415.0 million to $2,421.0 million, implying a 15.2% to 15.5% year-over-year revenue growth.</li>
<li>Fiscal year 2024 Non-IFRS Adjusted Profit from Operations Margin is estimated to be in the range of 15.0% to 15.5%.</li>
<li>Fiscal year 2024 Non-IFRS Adjusted Diluted EPS is estimated to be in the range of $6.37 to $6.43 (assuming an average of 44.5 million diluted shares outstanding during 2024).</li>
</ul>

GLOB

Globant S.A. Sees Q4 Adj. EPS $1.71-$1.75 Vs $1.74 Est.; Revenue $642M-$648M Vs $643M Est.; FY24 EPS $6.37-$6.43 Vs $6.40 Est.; Revenue $2.415B-$2.421B Vs $2.42B Est.

Panbela Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBLA#NASDAQ">PBLA</a>) reported quarterly losses of $(1.48) per share. This is a 97.25 percent increase over losses of $(53.74) per share from the same period last year.

PBLA

Panbela Therapeutics Q3 EPS $(1.48) Up From $(53.74) YoY

SWK Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWKH#NASDAQ">SWKH</a>) reported quarterly earnings of $0.33 per share which missed the analyst consensus estimate of $0.52 by 36.54 percent. The company reported $10.418 million in sales this quarter. This is a 16.25 percent increase over sales of $8.962 million the same period last year.

SWKH

SWK Holdings Q3 2024 Adj. EPS $0.33 Misses $0.52 Estimate, Sales $10.418M Up From $8.962M YoY

GameSquare Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAME#NASDAQ">GAME</a>) sees FY2024 sales of $105.000 million-$110.000 million vs $103.00 million estimate.

GAME

GameSquare Holdings Sees FY2024 Sales $105.000M-$110.000M vs $103.00M Est

POLA

Polar Power Q3 EPS $0.00 Up From $(0.14) YoY; Revenue $4.914M Up From $1.911M YoY

Globant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) reported quarterly earnings of $1.63 per share which met the analyst consensus estimate. This is a 10.14 percent increase over earnings of $1.48 per share from the same period last year. The company reported quarterly sales of $614.67 million which missed the analyst consensus estimate of $614.82 million by 0.02 percent. This is a 12.72 percent increase over sales of $545.28 million the same period last year.

Globant Q3 Adj $1.63, Inline, Sales $614.67M Miss $614.82M Estimate

Esco Technologies Sees FY25 Net Sales $1.09B-$1.11B, Adj. EPS $4.70-$4.90l Sees Q1 2025 Adj. EPS $0.68-$0.75

McRae declares $0.14 dividend and a special dividend of $0.61

McRae GAAP EPS of $1.43, revenue of $32.83M

McRae Industries, Inc. declares $0.14 dividend

McRae Industries, Inc. goes ex dividend tomorrow

McRae declares $0.14 dividend

MCRAA

MCRAB

Dividends

Small Cap

Press Releases

McRae Industries, Inc. Dividend Declared

McRAE INDUSTRIES, INC. REPORTS EARNINGS FOR THE FIRST QUARTER OF FISCAL 2024

McRAE INDUSTRIES, INC. REPORTS EARNINGS FOR THE SECOND QUARTER AND FIRST SIX MONTHS OF FISCAL 2024

McRAE INDUSTRIES, INC. REPORTS EARNINGS FOR THE THIRD QUARTER AND FIRST NINE MONTHS OF FISCAL 2024

Monday marks the last chance for investors to receive the next dividend payout from McRae Industries (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MCRAB#OTC">MCRAB</a>). 
<h3>What's Happening</h3>
The company announced on Thursday that it would pay shareholders a quarterly dividend of $0.13 per share. On Tuesday, McRae Industries will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open $0.13 lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Tuesday. Shareholders who own MCRAB as of the end of Monday's session are eligible to receive the $0.13 dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on March 30, 2022. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
To read more news on McRae Industries <a href="https://www.benzinga.com/stock//">click here</a>
<a href="https://www.benzinga.com/calendars/dividends">Click here</a> to visit our Dividends Calendar.

Comments

McRae Industries

News

Latest news for McRae Industries (OTC:MCRAB) Stock

Thursday, March 10, 2022

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga